Artificial intelligence (AI) is reshaping the pharmaceutical industry, particularly in the realm of drug manufacturing. As AI continues to evolve and integrate with industry practices, it is imperative to consider the accompanying challenges and potential solutions. In this essay, we will review a recent paper published by the FDA, title Artificial Intelligence in Drug Manufacturing, and explore the implications of AI applications in pharmaceutical manufacturing, its influence on data management and oversight, the potential regulatory hurdles, and the need for industry standards for AI models.
AI and Cloud Applications: A New Horizon for Data Oversight
AI has emerged as a
